NanoViricides Reports Effectiveness Of Antiviral Clinical Drug Candidate NV-387 In An Animal Model Of Lethal Lung Infection With Respiratory Syncytial Virus
NanoViricides Reports Effectiveness Of Antiviral Clinical Drug Candidate NV-387 In An Animal Model Of Lethal Lung Infection With Respiratory Syncytial Virus
nanoViricides 報告了抗病毒臨床候選藥物 NV-387 在呼吸道合胞病毒致命肺部感染動物模型中的有效性
NanoViricides Reports Effectiveness Of Antiviral Clinical Drug Candidate NV-387 In An Animal Model Of Lethal Lung Infection With Respiratory Syncytial Virus
nanoViricides 報告了抗病毒臨床候選藥物 NV-387 在呼吸道合胞病毒致命肺部感染動物模型中的有效性
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。